Astellas Pharma subsidiary, iota Biosciences, has won an investigational device exemption (IDE) from the US Food and Drug ...
Astellas Pharma is to buy bioelectronic medical devices firm iota Biosciences in a deal worth up to $429m, building on a previous research partnership. In August last year the companies began a ...